Remitch Soft Capsule 2.5 Micrograms (Nalbufin Hydrochloride)

Adult dose

Adults: Take 1 capsule (equivalent to 2.5㎍ of nalfurafine hydrochloride) orally once daily after the evening meal. The maximum daily dose is 5㎍ once daily.

This medicine should not be used by individuals who are allergic to this medicine or its components, or by children under 18 years of age. Patients with moderately to severely impaired liver function, pregnant women, or those who might become pregnant, as well as elderly individuals should exercise increased caution when using this medicine. This medication can frequently cause symptoms such as insomnia, constipation, and drowsiness, so the patient's condition should be carefully monitored after administration. Liver function test results may rise, or jaundice symptoms may appear; if these symptoms occur, immediately stop taking the medicine and consult a doctor. Since this medicine can be removed by hemodialysis, patients undergoing dialysis should take this medication at least 8 hours apart from their dialysis sessions. Drowsiness or dizziness may occur while taking this medicine, so it is advisable to avoid driving or operating hazardous machinery. If the medicine is taken without any noticeable effect, care should be taken to not use it for an extended period of time. When taken with drugs that inhibit certain liver metabolic enzymes or with some sedatives, anxiolytics, etc., the side effects may be more severe, so it is essential to consult a doctor or pharmacist when taking this medicine with others. Pregnant women are advised not to take this drug, and nursing mothers should also avoid it as it can be passed through breast milk. In the case of children or the elderly, since the safety and efficacy of this medicine have not been sufficiently confirmed or bodily functions may be impaired, greater caution is necessary when administering it. In case of overdose, symptoms such as hallucinations, anxiety, severe drowsiness, and insomnia may occur; if such symptoms are present, stop taking the medicine immediately and seek appropriate treatment. This medicine must be stored in its original packaging, out of reach of children, and kept away from direct sunlight. Once the blister pack is opened, it should be taken immediately, and transferring it to another container may cause degradation in quality or accidents.

• Insomnia
• constipation
• drowsiness
• increased prolactin
• dizziness
• restlessness
• headache
• hallucination
• tremor
• numbness

This medicine is sensitive to light; it should be stored in a container that does not allow light to enter. Additionally, it is important to store it at room temperature, between 1 to 30 degrees Celsius, until use. This will help maintain the efficacy of the medicine.

Appearance

Very light yellow to light yellow oval soft capsule containing a colorless transparent viscous liquid.

Package unit

14 capsules in PTP packaging